J&J withdrawing acid reflux device outside U.S., Bloomberg reports

Johnson & Johnson is withdrawing the Linx Reflux Management System from markets outside the U.S., citing a commercial decision unrelated to the device’s safety or efficacy, Bloomberg’s Ashleigh Furlong reports. The withdrawal of the Linx device will deprive patients of a treatment option for gastroesophageal reflux disease, and will also impact lung transplant patients, who often require treatment for GERD to prevent rejection of the transplanted organ, with the Linx device having been used for this purpose in some cases, according to the report.